Open access · OA
via OpenAlex
Senolytic Development in Osteoarthritis: A New Paradigm
Authors not listed
Integrative Journal of Orthopaedics and Traumatology · 2021
Abstract
advances in the biology of aging will be at the origin of therapeutical improvement making it possible to increase life expectancy in good health and prevent OA. Senescence(definition) and OA PhysiopathologySenescence is a complex pathophysiological phenomenon that can be observed in the context of tissue damage associated with aging in the context of cancer development.Cellular senescence is a cell Abstract OA is a large unmet medical need, with increasing incidence in our aging population.Recent physiopathogical knowledge have identified the accumulation of senolytic cells in cartilage and the synovium as deleterious.This has prompted the development of senolytic drugs in OA.Senolytics(definition) are a class of drugs that selectively clear senescent cells.Senolytics induce apoptosis of senescent cells accumulated in joint tissue with a tissue-destructive SASP (senescent associated secreted proteome).They include three major classes of molecules.Senolytics which seek to kill/eliminate senescent cells by playing on increased cell survival pathways during the senescence process.Seno-morphics, which change the inherent properties of the senescent state, for example by reactivating autophagy(definition) while maintaining the stopping of the cycle.And finally, a third class of therapeutic agents, senosuppressants, will block the entry or the spread of senescence.Thus, drugs with senotherapy properties such as metformin, mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), fisetin, dasatinib, quercetin, resveratrol, have shown modulation of the aging process and associated pathologies including OA.Thus, many therapeutic alternatives in the treatment of osteoarthritis are opening up, but clinical trials will have to be carried out to confirm their effectiveness.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.31038/ijot.2021422
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Anonymous. (2021). Senolytic Development in Osteoarthritis: A New Paradigm. <em>Integrative Journal of Orthopaedics and Traumatology</em>. https://doi.org/10.31038/ijot.2021422
Vancouver
Anonymous. Senolytic Development in Osteoarthritis: A New Paradigm. Integrative Journal of Orthopaedics and Traumatology. 2021. doi:10.31038/ijot.2021422.
BibTeX
@article{anon2021Senoly,
title = {Senolytic Development in Osteoarthritis: A New Paradigm},
author = {Anonymous},
journal = {Integrative Journal of Orthopaedics and Traumatology},
year = {2021},
doi = {10.31038/ijot.2021422},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging 2023
Open access · CC-BY
Cellular senescence with SASP in periodontal ligament cells triggers inflammation in aging periodontal tissue
Drug Discovery Today 2017
Open access · CC-BY
Therapeutic interventions for aging: the case of cellular senescence
Frontiers in Aging Neuroscience 2025
Open access · CC-BY
Current aspects of targeting cellular senescence for the therapy of neurodegenerative diseases
Cancer Science 2024
Open access · CC-BY
Senescence and senolysis in cancer: The latest findings
BMB Reports 2019
Open access · CC-BY
Cellular senescence, aging, and age-related disease: Special issue of BMB Reports in 2019
Expert Review of Proteomics 2020
Open access · CC-BY